Alvotech (ALVO) Other Non Operating Income (2021 - 2026)
Alvotech's (ALVO) quarterly Other Non Operating Income came in at -$1.3 million in Q1 2026, up 83.67% YoY from -$705070.4 in Q1 2025, and down 100.07% on a QoQ basis from $2.0 billion in Q4 2025.
Alvotech (ALVO) Other Non Operating Income (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Other Non Operating Income data on file, last reported at -$1.3 million in Q1 2026.
- Quarterly Other Non Operating Income rose 83.67% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (up 135053.38% YoY) and the FY2025 annual result came in at -$16.8 million, down 306.36% from the prior year.
- Other Non Operating Income declined to -$1.3 million in Q1 2026, from $2.0 billion in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.0 billion in Q4 2025 to a low of -$11.8 million in Q2 2025.
- A 5-year average of $131.7 million and a median of -$1.3 million in 2026 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 25619.01% in 2025, down 121502.33% in 2025.
- Tracing ALVO's Other Non Operating Income over 5 years: stood at $4.7 million in 2022, then sank by 209.25% to -$5.2 million in 2023, then jumped by 249.37% to $7.7 million in 2024, then soared by 25619.01% to $2.0 billion in 2025, then sank by 100.07% to -$1.3 million in 2026.
- The last three Other Non Operating Income figures came in at -$1.3 million (Q1 2026), $2.0 billion (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alvotech | 1.18 Bn | 1.18 Bn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.30 Mn |
| Dec 31, 2025 | 1.99 Bn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -11.75 Mn |
| Mar 31, 2025 | -7.93 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | -6.09 Mn |
| Jun 30, 2024 | 7.74 Mn |
| Mar 31, 2024 | 6,532.00 |
| Dec 31, 2023 | -5.18 Mn |
| Aug 31, 2023 | -3.08 Mn |
| Jun 30, 2023 | -3.08 Mn |
| Mar 31, 2023 | -1,748.00 |
| Dec 31, 2022 | 4.74 Mn |
| Aug 31, 2022 | 4.74 Mn |
| Dec 31, 2021 | -553,000.00 |
| Sep 30, 2021 | 6.85 Mn |